Does METHYLPREDNISOLONE Cause Basal cell carcinoma? 74 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 74 reports of Basal cell carcinoma have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.1% of all adverse event reports for METHYLPREDNISOLONE.
74
Reports of Basal cell carcinoma with METHYLPREDNISOLONE
0.1%
of all METHYLPREDNISOLONE reports
18
Deaths
23
Hospitalizations
How Dangerous Is Basal cell carcinoma From METHYLPREDNISOLONE?
Of the 74 reports, 18 (24.3%) resulted in death, 23 (31.1%) required hospitalization, and 7 (9.5%) were considered life-threatening.
Is Basal cell carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 74 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which METHYLPREDNISOLONE Alternatives Have Lower Basal cell carcinoma Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE